Sach, T., Thomas, K., Batchelor, J., Perways, A., Chalmers, J., Haines, R., Meakin, G., Duley, L., Ravenscroft, J., Rogers, A., Santer, M., Tan, W., White, J., Whitton, M., Williams, H., Cheung, S., Hamad, H., Wright, A., Ingram, J., Levell, N., Goulding, J., Makrygeorgou, A., Bewley, A., Ogboli, M., Stainforth, J., Ferguson, A., Laguda, B., Wahie, S., Ellis, R., Azad, J., Rajasekaran, A., Eleftheriadou, V., Montgomery, A., & , (2021). an economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial)*. British journal of dermatology, 184, 840–848. http://access.bl.uk/ark:/81055/vdc_100172209698.0x000022